Header Logo

Connection

JONATHAN LEI to Mutation

Back to Details
This is a "connection" page, showing publications JONATHAN LEI has written about Mutation.
JONATHAN LEI
Connection Strength
0.289
Mutation
  1. Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer. Cancer Res. 2021 12 15; 81(24):6259-6272.
    View in: PubMed
    Score: 0.074
  2. Endocrine therapy resistance: new insights. Breast. 2019 Nov; 48 Suppl 1:S26-S30.
    View in: PubMed
    Score: 0.065
  3. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 06 02; 534(7605):55-62.
    View in: PubMed
    Score: 0.051
  4. Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomics. Nat Cancer. 2025 Jan; 6(1):205-222.
    View in: PubMed
    Score: 0.023
  5. Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023 10 02; 83(19):3237-3251.
    View in: PubMed
    Score: 0.021
  6. Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness. Sci Adv. 2023 06 30; 9(26):eadf2860.
    View in: PubMed
    Score: 0.021
  7. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021 08 05; 184(16):4348-4371.e40.
    View in: PubMed
    Score: 0.018
  8. Neurofibromin Is an Estrogen Receptor-a Transcriptional Co-repressor in Breast Cancer. Cancer Cell. 2020 03 16; 37(3):387-402.e7.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.